Genespire

📍 Milan, Italy🗓 Founded 2020👥 16 employees💰 Last funded Jul 2024
Biotechnology Research🌐 genespire.com
Website LinkedIn
Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini, Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele. It is a spin-off of SR-Tiget, a world leading cell and gene therapy research institute and is backed by Sofinnova Partners.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
Italy
1
Frequently asked questions
Who invested in Genespire?
Genespire has 2 investors on record on gritt.io, 2 mid-stage.
When did Genespire last raise funding?
The most recent investment in Genespire recorded on gritt.io was in July 2024.
When was Genespire founded?
Genespire was founded in 2020.
What industry is Genespire in?
Genespire operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Genespire based?
Genespire is headquartered in Milan, Italy.